Company expects to begin shipping the 15-dose vials within weeks<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
FRIDAY, April 2, 2021 (HealthDay News) — Moderna has been authorized to put 50 percent more COVID-19 vaccine into its vials, the U.S. Food and Drug Administration said Thursday.<\/p>\n
The company had already started producing fuller vials (15 doses instead of 10) in anticipation of the approval and said in a statement that it expects to begin shipping the 15-dose vials within weeks.<\/p>\n
The FDA approval provides fresh assurance about the supply of the Moderna two-dose vaccine. The company has promised to deliver 200 million doses by the end of May and 300 million by the end of July.<\/p>\n
Approval of the fuller vials comes a day after it was announced that a production error ruined up to 15 million doses of the Johnson & Johnson single-dose vaccine, which delayed FDA authorization of the Baltimore plant where that vaccine is being manufactured.<\/p>\n
All shipments from the plant have been delayed until the FDA completes its investigation and decides whether to approve vaccine production at the plant. Even, so Johnson & Johnson says it will still be able to deliver its promised 24 million doses of vaccine this month.<\/p>\n